NRI

Alpa Laboratories Ltd

Sector Pharmaceuticals
BSE 532878
NSE ALPA
114.80
11.46 (11.09 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

107.01

Day High

117.00

52 Week Low

69.90

52 Week High

144.50

All Time Low

5.10

All Time High

144.50

Open

107.01

Close

103.34

Volume

147,036

Mkt cap (Cr)

241.55

P/E ratio

10.51

P/B ratio

0.76%

Div yield

0.00%

6M return

24.89%

1Y return

13.61%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

114.80 11.09%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About Alpa Laboratories Ltd

Stock PE (TTM)

10.51

Promoter Holding

57.29%

Book Value

78.2355

ROCE

14.32%

ROE

11.71%

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals. The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company`s business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008. The Unit-II oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hi-potency formulations was made operational at Pithampur Industrial Area in 2012. The Company in FY 2014-15, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.

Alpa Laboratories share price as on 14 Feb 2025 is Rs. 114.8. Over the past 6 months, the Alpa Laboratories share price has increased by 24.89% and in the last one year, it has increased by 13.61%. The 52-week low for Alpa Laboratories share price was Rs. 69.9 and 52-week high was Rs. 144.5.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

532878

ALPA

INE385I01010

Sep

Alpa Laboratories Ltd FAQs

You can buy Alpa Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Alpa Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 14, 2025 09:54 AM the closing price of Alpa Laboratories Ltd was Rs.114.80.

The latest PE ratio of Alpa Laboratories Ltd as of Feb 14, 2025 09:54 AM is 10.51

The latest PB ratio of Alpa Laboratories Ltd as of Feb 14, 2025 09:54 AM is 0.76

The 52-week high of Alpa Laboratories Ltd share price is Rs. 144.50 while the 52-week low is Rs. 69.90

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Feb 14, 2025 09:54 AM, the market cap of Alpa Laboratories Ltd stood at Rs. 241.55 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.